Purpose: To evaluate the incidence, associated factors, and outcome of persistent subretinal fluid (SRF) after vitrectomy for macular hole-associated retinal detachment (MHRD).
Methods: A total of 158 eyes from 156 patients with MHRD who achieved macular hole closure after primary vitrectomy were included in the analysis; persistent SRF was defined as the presence of SRF for more than 1 month after first surgery. Preoperative and postoperative parameters were analyzed for their relationship with SRF development.
Results: Persistent SRF was observed in 19 eyes (12.0% of 158) postoperatively. Seven eyes (36.8% of 19) with persistent SRF eventually displayed complete absorption during follow-up. Univariate analysis revealed that eyes with persistent SRF were statistically associated with internal limiting membrane inverted flap, duration of symptoms, tamponade (perfluoropropane/silicone oil: 14/5 vs. 35/104, P < 0.001), and MHRD subtype (Type 1/Type 2/Type 3: 15/4/0 vs. 60/40/39, P = 0.003). In multivariate analysis, only internal limiting membrane inverted flap (odds ratio, 15.778, 95% confidence interval, 3.170-78.523; P = 0.001) was positively associated with persistent SRF. There were no significant differences in best-corrected visual acuity improvement ( P = 0.425) between the SRF involved foveal and without involved foveal groups and no significant differences between the SRF complete absorption and incomplete absorption groups.
Conclusion: Absorption of persistent SRF may be more difficult in MHRD eyes than in ordinary rhegmatogenous retinal detachment eyes. The internal limiting membrane inverted flap in MHRD was associated with a greater likelihood of persistent SRF. The location and incomplete absorption of persistent SRF did not seem to be associated with the final visual outcome.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/IAE.0000000000004050 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
First-year real-world experience of intravitreal brolucizumab injection for refractory neovascular age-related macular degeneration.
Jpn J Ophthalmol
November 2024
Department of Ophthalmology, Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea.
Article Synopsis
- The study aimed to assess the real-world effectiveness of brolucizumab injections for patients with neovascular age-related macular degeneration (nAMD) who did not respond to previous treatments.
- Results showed that while visual acuity (BCVA) remained stable, anatomical improvements were noted, such as decreased central foveal thickness (CFT) and reduced presence of subretinal fluid (SRF) and pigment epithelial detachment (PED) after switching to brolucizumab.
- The safety profile was acceptable, with a low incidence of intraocular inflammation-related adverse events reported among the patients.
Fluid Resolution Without Shortening Injection Interval During Subretinal Fluid-tolerating Treatment in Neovascular Age-related Macular Degeneration.
Retina
October 2024
Department of Ophthalmology, Kim's Eye Hospital, Seoul, South Korea.
Purpose: To investigate the incidence and factors associated with subretinal fluid(SRF) resolution during SRF-tolerating treatment in patients with neovascular age-related macular degeneration(AMD).
Methods: This retrospective study included patients diagnosed with neovascular AMD who exhibited fovea-involving residual SRF persisting for at least 6 months during aflibercept treatment. Patients who showed SRF resolution despite maintaining the injection intervals were included in the resolution group, while those who exhibited persisting SRF throughout the study period were included in the non-resolution group.
Differential inhibition of tire wear particles on sludge dewatering by aging modes.
J Hazard Mater
December 2024
School of Environmental Science and Engineering, Nanjing University of Information Science and Technology, Nanjing 210044, China; Jiangsu Key Laboratory of Atmospheric Environment Monitoring and Pollution Control, Jiangsu Collaborative Innovation Center of Atmospheric Environment and Equipment Technology, Nanjing 210044, China.
The study assessed the acute toxicities of tire wear particles (TWPs) on activated sludge, comparing cryogenically ground TWPs (C-TWPs) with photo-aged (PA-TWPs), ozone-aged (OA-TWPs), and Fenton-aged (FA-TWPs) variants over 96 h. At 0.1 mg/L, TWPs showed no significant effects on sludge respiration or purification.
View Article and Find Full Text PDFInfluence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy.
Sci Rep
October 2024
Department of Ophthalmology, Yeungnam University College of Medicine, #170 Hyunchungro, Nam-gu, Daegu, 42415, Korea.
Article Synopsis
- * Thirty-six patients with CSC who had not been treated before underwent various evaluations, including assessing the fluid in the eyes and changes in vision over 12 months.
- * Results showed that a higher number of these swollen veins was linked to ongoing fluid issues and negative impacts on visual recovery, indicating that more veins might lead to worse outcomes after PDT treatment.
Flexible X-ray Imaging and Stable Information Storage of SrF:Eu Based on Radio-Photoluminescence.
ACS Appl Mater Interfaces
October 2024
Key Laboratory of Advanced Display and System Applications of Ministry of Education, Shanghai University, Shanghai 200444, PR China.
Article Synopsis
- X-ray imaging is gaining traction in biomedical diagnosis, but prolonged imaging of curved objects remains challenging due to attenuation issues.
- * The study focuses on europium-doped strontium fluoride (SrF:Eu), which can handle high X-ray doses and demonstrates impressive reusability and long-lasting photoluminescent properties.
- * The research proposes a mechanism for how SrF:Eu retains information effectively, showcasing its potential for advanced imaging, optical information encryption, and anticounterfeiting uses.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!